<format type="yaml">{report_id: string, report_date: date, patient_details: {patient_id: string, age_at_reaction: number optional, gender: string, relevant_history: list[string]}, suspected_drugs: list[{drug_name: string, drug_class: string optional, dosage: string, route_of_administration: string, start_date: date, end_date: date optional, indication_for_use: string}], adverse_reactions: list[{symptom_name: string, onset_date: date, severity: string, outcome: string, intervention_required: boolean, intervention_details: string optional}], causality_assessment: {naranjo_score: number optional, assessment_conclusion: string, dechallenge_rechallenge: string}, reporting_facility: string, reporter_type: string, notes: string optional}</format> <data>PHARMACOVIGILANCE CASE REPORT - CONFIDENTIAL
Report Identifier: ADR-2024-501
Date of Submission: 2024-11-15

This report was submitted by a Patient from Morales Group Medical Center concerning patient ANON-PX-7560. The subject is a 26-year-old male with a significant medical history including type 2 diabetes, anxiety, coronary artery disease, chronic kidney disease. The facility's standard operating procedure for ADR reporting was followed, and all patient data has been anonymized. The patient chart was reviewed for comorbidities. 

Current medication review revealed the following suspected agent(s): Amoxicillin administered via the Subcutaneous route at a dosage of 445mg, initiated on 2024-09-04 for Bacterial infection and discontinued on 2024-10-07.

On approximately 2024-10-07, the patient began to manifest an adverse event. The primary symptoms noted in the clinical log were Diarrhea, Vomiting, Somnolence. The Diarrhea was classified as Life-threatening in severity. No specific therapeutic intervention was required. The current patient status regarding this symptom is 'Fatal'. The Vomiting was classified as Mild in severity. No specific therapeutic intervention was required. The current patient status regarding this symptom is 'Fatal'. The Somnolence was classified as Life-threatening in severity. This necessitated clinical intervention. The current patient status regarding this symptom is 'Not Recovered'. 

CAUSALITY ASSESSMENT:
An evaluation of causality was performed. The assessment concluded the relationship was 'Probable'. Dechallenge/Rechallenge status was noted as: 'Positive dechallenge'. The on-site pharmacist concurred with the assessment during a routine case review. 

Reporter's Narrative Summary: Discover product hard concern. All discussion daughter change TV direction each.</data>
report_id: ADR-2024-501
report_date: '2024-11-15'
patient_details:
  patient_id: ANON-PX-7560
  gender: Male
  relevant_history:
  - type 2 diabetes
  - anxiety
  - coronary artery disease
  - chronic kidney disease
  age_at_reaction: 26
suspected_drugs:
- drug_name: Amoxicillin
  dosage: 445mg
  route_of_administration: Subcutaneous
  start_date: '2024-09-04'
  indication_for_use: Bacterial infection
  end_date: '2024-10-07'
adverse_reactions:
- symptom_name: Diarrhea
  onset_date: '2024-10-07'
  severity: Life-threatening
  outcome: Fatal
  intervention_required: false
- symptom_name: Vomiting
  onset_date: '2024-10-07'
  severity: Mild
  outcome: Fatal
  intervention_required: false
- symptom_name: Somnolence
  onset_date: '2024-10-07'
  severity: Life-threatening
  outcome: Not Recovered
  intervention_required: true
causality_assessment:
  assessment_conclusion: Probable
  dechallenge_rechallenge: Positive dechallenge
reporting_facility: Morales Group Medical Center
reporter_type: Patient
notes: Discover product hard concern. All discussion daughter change TV direction
  each.
